Clinical Trial Search

Primary: Number of Participants With Clinical Cure as of the Test-of-Cure (TOC) Visit in the Per Protocol Population — 457; 487; 182; 187 participants

Primary: Blood Glucose Measurements — 97.38; 95.04; 97.00; 92.38 mg/dL

Primary: Percentage of Participants With Sustained Virologic Response 24 Weeks Following Completion of Treatment (SVR24) — 90.4; 92.7; 91.0; 93.3 percentage of participants…

Primary: Change From Baseline to Week 12 After Trial Entry in Osteoarthritis Pain Measured on the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain…

Primary: Number of Patients Maintaining or Improving Their Health Status — 972 participants

Primary: Improvement in Obtaining Lift and Tightening of Brachial Skin Laxity — 48 percentage of participants improved

Primary: Patient Acceptance — 1.7; 3.9 units on a scale

Primary: Clinical Benefit Rate (Complete Response, Partial Response, or Stable Disease) — 9.7 percentage of participants

Primary: Total Opioid Consumption in the Postoperative Period — 8; 14 milligrams

Primary: Number of Participants Sustained Virological Response (SVR) Following Treatment of Hepatitis C Virus (HCV) Infection With Peg-IFN and Ribavirin in Liver Transplanted…

Primary: Percentage of Participants Undergoing Conversion to Peginesatide Injection — 88 percentage of participants

Primary: Assess the Therapeutic Equivalence of Eprosartan (a New Formulation Containing Only the Active Moiety Eprosartan) With Eprosartan Mesylate (Currently Marketed…

Primary: Change in Ki (Measure of [18F]Fluorodeoxyglucose ([18F]FDG) Uptake Determined by Patlak Graphical Analysis) in the Right Lung 24 Hours After LPS Instillation — 18.8…

Primary: Mean Arterial Blood Pressure — 110; 95; 106 mm Hg

Primary: Objective Response Rate by Investigator — 60; 91; 33; 68 percentage of retreatment experiences